ADMA Biologics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by ADMA Biologics, Inc. on March 26, 2014, reporting events occurring on March 25, 2014. The filing addresses corporate governance matters regarding the scheduling of the company's 2014 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate event notifications and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the Board of Directors' decision to set the date for the 2014 Annual Meeting and the corresponding record date.
Guidance, Outlook, and Management Commentary
- Annual Meeting Date: Fixed for June 19, 2014.
- Record Date: Set for April 25, 2014.
- Proxy Materials: Expected to be printed and sent on or about May 12, 2014.
- Stockholder Proposals: Proposals for inclusion in the proxy statement must be received by April 4, 2014, pursuant to Rule 14a-8.
Key Facts for Investor Verification
- Verify the record date of April 25, 2014, to determine eligibility to vote at the Annual Meeting.
- Note the April 4, 2014, deadline for submitting stockholder proposals.
- Confirm the Annual Meeting date of June 19, 2014, for planning purposes.